Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
<sup>11</sup> C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
408
Zitationen
14
Autoren
2007
Jahr
Abstract
PET imaging with (11)C-labeled Pittsburgh Compound-B ((11)C-PIB) helps discriminate Alzheimer disease (AD) from frontotemporal lobar degeneration (FTLD). Pathologic correlation is needed to determine whether patients with PIB-positive FTLD represent false positives, comorbid FTLD/AD pathology, or AD pathology mimicking an FTLD clinical syndrome.
Ähnliche Arbeiten
The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research
1989 · 34.107 Zit.
Clinical diagnosis of Alzheimer's disease
1984 · 27.941 Zit.
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 · 24.946 Zit.
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 · 20.659 Zit.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 · 18.651 Zit.